Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
17,138,603
-
Share change
-
+415,423
-
Total reported value
-
$1,456,817,692
-
Price per share
-
$85.25
-
Number of holders
-
221
-
Value change
-
+$35,591,032
-
Number of buys
-
81
-
Number of sells
-
94
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2025
As of 31 Dec 2025,
Edwards Lifesciences Corp - Common Stock (EW) was held by
221 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,138,603 shares.
The largest 10 holders included
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, NORDEA INVESTMENT MANAGEMENT AB, Assenagon Asset Management S.A., Seilern Investment Management Ltd, Allspring Global Investments Holdings, LLC, SG Americas Securities, LLC, OFI INVEST ASSET MANAGEMENT, Aberdeen Group plc, AMIRAL GESTION, and NISA INVESTMENT ADVISORS, LLC.
This page lists
221
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.